Log in to save to my catalogue

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and t...

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dcc4b858e6cf4302b344a449e625a03f

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis

About this item

Full title

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis

Publisher

England: John Wiley & Sons, Inc

Journal title

Clinical case reports, 2021-05, Vol.9 (5), p.e03971-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis.
EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This e...

Alternative Titles

Full title

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dcc4b858e6cf4302b344a449e625a03f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dcc4b858e6cf4302b344a449e625a03f

Other Identifiers

ISSN

2050-0904

E-ISSN

2050-0904

DOI

10.1002/ccr3.3971

How to access this item